alphaveMARKSANS₹329.00

Marksans Pharma Ltd.

₹ CrorePeersGRANULES METROPOLIS PARKHOSPS JLHL HCG RUBICON SHILPAMED SPARCMcap ₹14,909 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	675.7	57.9	625.0	625.0
+ Capital Work-in-Progress	5.4	0.9	14.8	14.8
+ Goodwill	39.5	4.1	45.3	45.3
+ Other Intangibles	60.7	36.2	73.0	73.0
+ Intangibles under Development	4.0	1.8	43.8	43.8
+ Other Non-current Financial Assets	2.6	0.4	3.9	3.9
Non-current Financial Assets	2.6	0.4	3.9	3.9
+ Deferred Tax Assets	1.1	0.1	13.0	13.0
+ Other Non-current Assets	29.4	2.2	319.5	319.5
Total Non-current Assets	818.5	103.6	1,138.2	1,138.2
Current Assets
+ Inventories	617.9	84.6	972.3	972.3
+ Current Investments	27.0	0.1	0.0	0.0
+ Trade Receivables	453.2	54.0	644.6	644.6
+ Cash & Cash Equivalents	403.3	49.6	634.1	634.1
+ Other Bank Balances	270.3	20.8	355.5	355.5
+ Other Current Financial Assets	6.9	0.4	116.2	116.2
Current Financial Assets	1,160.6	124.9	1,750.5	1,750.5
+ Other Current Assets	79.0	9.8	100.5	100.5
Total Current Assets	1,862.5	220.4	2,722.7	2,722.7
Total Assets	2,681.0	324.0	3,860.9	3,860.9
Equity
+ Equity Share Capital	45.3	4.5	45.3	45.3
+ Other Equity / Reserves	2,019.7	242.2	2,977.8	2,977.8
Equity — Owners of Parent	2,065.1	246.7	3,023.2	3,023.2
+ Minority Interest	20.9	2.2	29.5	29.5
Total Equity	2,085.9	248.9	3,052.7	3,052.7
Liabilities
+ Other Non-current Financial Liab	190.0	26.3	270.1	270.1
Non-current Financial Liabilities	190.0	26.3	270.1	270.1
+ Provisions — Non-current	4.6	0.6	5.9	5.9
+ Deferred Tax Liabilities	10.6	0.4	5.1	5.1
Non-current Liabilities	205.2	27.3	281.1	281.1
+ Borrowings — Current	29.1	2.3	29.6	29.6
+ Trade Payables	268.3	30.6	336.9	336.9
+ Other Current Financial Liab	40.4	5.9	73.8	73.8
Current Financial Liabilities	337.7	38.8	440.3	440.3
+ Provisions — Current	2.0	0.1	0.3	0.3
+ Current Tax Liabilities	19.9	3.0	41.6	41.6
+ Other Current Liabilities	30.2	5.8	44.9	44.9
Current Liabilities	389.8	47.7	527.1	527.1
Total Liabilities	595.0	75.0	808.2	808.2
Total Equity & Liabilities	2,681.0	324.0	3,860.9	3,860.9
Assets — additional as-filed lines
+ Current Tax Assets	4.9	1.2	1.1	1.1
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	0.4	2.0	2.0
+ Dues to Other Creditors — Current	—	30.2	334.9	334.9

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.